FREEMAN MASON (EVP Clinical Development) received a stock award from CINCOR PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/30/2023ACC: 0001209191-23-005588
Officer· EVP Clinical Development
Since Jan 2022
+40K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
40K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40K
Price / share
—
Trade value
—
% of position
1600.0%
1/26/2023
2.50K→42.50K
Total
Net shares
+40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/26/2023 | A · Award | +40K | — | — | 1600.0% | 2.50K | 42.50K |
| Total | +40K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned100.00
Total
100.00 indirect100.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 100.00 | Indirect |
| Total | 100.00 | 100.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported